# FDA 483 - Memorial Hospital For Cancer & Allied Diseases - February 13, 2025

Source: https://www.globalkeysolutions.net/records/483/memorial-hospital-for-cancer-allied-diseases/5115195a-8b3a-459b-8435-8e34d30ce4b9

> FDA 483 for Memorial Hospital For Cancer & Allied Diseases on February 13, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Memorial Hospital For Cancer & Allied Diseases
- Inspection Date: 2025-02-13
- Product Type: biologics
- Office Name: New York District Office
- Summary: Memorial Hospital For Cancer & Allied Diseases, a blood bank in New York, was inspected and cited for significant deficiencies in record-keeping, donor notification, and standard operating procedures. Observations included failures to trace blood product storage, investigate cooler removals, notify deferred donors within the required timeframe, and establish proper SOPs for deviation investigations. These issues indicate a lack of adequate control over critical blood bank operations.

## Related Documents

- [483 - 2019-05-29](https://www.globalkeysolutions.net/records/483/memorial-hospital-for-cancer-allied-diseases/9e8a38e7-c98f-43c9-a00e-b7af5b01aac5)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.globalkeysolutions.net/companies/memorial-hospital-for-cancer-allied-diseases/52f00fc8-a958-4fce-b4bf-07f18baf51a2

Office: https://www.globalkeysolutions.net/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d